Series C-stage Healthcare AI investors
Healthcare AI investors writing series c-stage checks. Cross-referenced with portfolio holdings, sub-vertical focus, and check-size range so you can shortlist credible leads for your raise.
Series C funding is secured by highly mature startups aiming to scale aggressively on a global scale, develop entirely new product ecosystems, or execute major corporate acquisitions. Investors participating in Series C rounds—including private equity firms, hedge funds, and investment banks—face lower operational risks and focus primarily on maximizing the company's valuation ahead of a liquidity event.
254
investors match
Within Series C: top healthcare sub-verticals
RA Capital
VC
T1
Biotech
Diagnostics
Roche Venture Fund
Corporate VC
T3
Biotech
Diagnostics
SAIF Partners
VC
T2
Digital Health
Health IT / Healthcare Software
Samsara BioCapital
VC
T3
Biotech
Pharma / Therapeutics
Samsung Catalyst Fund
Corporate VC
T3
AI/ML in Healthcare
Digital Health
Samsung Ventures
Corporate VC
AI
T3
AI/ML in Healthcare
Digital Health
Sanabil Investments
PE
AI
T2
Biotech
Digital Health
Saudi Venture Capital Company (SVC)
VC
AI
T2
Digital Health
Health IT / Healthcare Software
SBVA
VC
AI
T3
AI/ML in Healthcare
Digital Health
Section 32
VC
T3
AI/ML in Healthcare
Biotech
Sequoia Capital
VC
T1
AI/ML in Healthcare
Biotech
Shanghai Biomedical Fund
PE
T3
Biotech
Pharma / Therapeutics
Shenzhen Capital Group
VC
AI
T3
AI/ML in Healthcare
Biotech
Sherpa Healthcare Partners
VC
AI
T3
Biotech
Diagnostics
Siana Capital
VC
AI
T2
AI/ML in Healthcare
Health IT / Healthcare Software